SE408426B - Sett att framstella d-homo-20-ketopregnaner - Google Patents

Sett att framstella d-homo-20-ketopregnaner

Info

Publication number
SE408426B
SE408426B SE7414960A SE7414960A SE408426B SE 408426 B SE408426 B SE 408426B SE 7414960 A SE7414960 A SE 7414960A SE 7414960 A SE7414960 A SE 7414960A SE 408426 B SE408426 B SE 408426B
Authority
SE
Sweden
Prior art keywords
calculators
keto
homo
way
make
Prior art date
Application number
SE7414960A
Other languages
English (en)
Swedish (sv)
Other versions
SE7414960L (en:Method
Inventor
U Kerb
R Wiechert
K Kieslich
K Petzoldt
H Wachtel
D Palenschat
R Horowski
G Paschelke
W Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7414960L publication Critical patent/SE7414960L/xx
Publication of SE408426B publication Critical patent/SE408426B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
SE7414960A 1973-11-30 1974-11-28 Sett att framstella d-homo-20-ketopregnaner SE408426B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
SE7414960L SE7414960L (en:Method) 1975-06-02
SE408426B true SE408426B (sv) 1979-06-11

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414960A SE408426B (sv) 1973-11-30 1974-11-28 Sett att framstella d-homo-20-ketopregnaner

Country Status (14)

Country Link
US (1) US4045574A (en:Method)
JP (1) JPS5084561A (en:Method)
AT (1) AT347611B (en:Method)
CA (1) CA1030522A (en:Method)
CH (1) CH618183A5 (en:Method)
DD (1) DD115659A5 (en:Method)
DK (1) DK134348C (en:Method)
ES (1) ES432106A1 (en:Method)
FR (1) FR2253512B1 (en:Method)
GB (1) GB1494097A (en:Method)
IE (1) IE40423B1 (en:Method)
IL (1) IL46153A (en:Method)
NL (1) NL7415577A (en:Method)
SE (1) SE408426B (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
ATE339437T1 (de) * 2002-08-16 2006-10-15 Pharmacia & Upjohn Co Llc 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
RS60420B1 (sr) 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
SI2986623T1 (sl) 2013-04-17 2019-03-29 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス, インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MX384728B (es) 2014-10-16 2025-03-14 Sage Therapeutics Inc Composiciones para el tratamiento de trastornos del snc.
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
HUE049014T2 (hu) 2014-11-27 2020-09-28 Sage Therapeutics Inc Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére
WO2016123056A1 (en) 2015-01-26 2016-08-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
BR112020012761A2 (pt) * 2017-12-22 2021-02-17 Sage Therapeutics, Inc. composições e métodos para o tratamento de distúrbios do snc
CN113383004A (zh) 2018-12-05 2021-09-10 萨奇治疗股份有限公司 神经活性类固醇及其使用方法
CN111410678B (zh) 2019-01-08 2023-02-28 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
CA3143545A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compounds for treating cns disorders
AU2020304673A1 (en) * 2019-06-27 2022-01-20 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
DK134348B (da) 1976-10-25
ATA950774A (de) 1978-05-15
US4045574A (en) 1977-08-30
IL46153A0 (en) 1975-02-10
SE7414960L (en:Method) 1975-06-02
FR2253512B1 (en:Method) 1978-02-03
DK604174A (en:Method) 1975-07-28
AU7586774A (en) 1976-06-03
AT347611B (de) 1979-01-10
DD115659A5 (en:Method) 1975-10-12
DK134348C (da) 1977-03-21
ES432106A1 (es) 1976-11-01
IL46153A (en) 1979-01-31
JPS5084561A (en:Method) 1975-07-08
CA1030522A (en) 1978-05-02
IE40423L (en) 1975-05-30
IE40423B1 (en) 1979-05-23
NL7415577A (nl) 1975-06-03
GB1494097A (en) 1977-12-07
FR2253512A1 (en:Method) 1975-07-04
CH618183A5 (en:Method) 1980-07-15

Similar Documents

Publication Publication Date Title
SE408426B (sv) Sett att framstella d-homo-20-ketopregnaner
IT1019129B (it) Calcolatrice elettronica
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE411545B (sv) Sett att framstella chalkonetrar.
IT980896B (it) Perfezionamenti alle calcolatri ci elettroniche
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE421371B (sv) Sett att framstella leverkorv
SE387250B (sv) Sett att separera flytande fretande substansblandningar
SE382215B (sv) Sett att framstella kromanderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE401176B (sv) Sett att framstella nya hypokalcemiskt verksamma dotriakontapeptidamider
SE418205B (sv) Sett att framstella flerskiktskartong
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE425850B (sv) Sett att framstella abietamidderivat.
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner
SE388142B (sv) Sett att gjuta lettmetallgot